Shefflette A, Patel N, Caruso J
Conclusions The real-world evidence presented in this study indicates that switching to semaglutide OW from liraglutide OD or dulaglutide OD is associated with further reductions in HbA1c, weight, and BMI in patients with T2DM
The peptide stimulates production of VEGF (vascular endothelial growth factor) and HGF (hepatocyte growth factor), both critical for building new capillary networks
Di y, edallyhanquoc.vn xin tng hp mt vi iu v hot cht ny mi ngi tham kho trc khi quyt nh s dng
Allergy 62 (11), 13411342
However, the risk of kidney disease should not be overlooked ( 2 Methods This systematic review of case reports was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement ( 2.1 Search strategies A comprehensive literature search was conducted using the PubMed/MEDLINE, Web of Science, Embase, the Cochrane Library, and CNKI databases to identify relevant case reports and case series published in English or Chinese from database inception to October 31, 2025